Healthcare Industry Insights

Tuesday, 10 November 2020

North America Breast Reconstruction Market Worth $486.6 Million By 2025

The North America Breast Reconstruction Market size is anticipated to reach USD 486.6 million by 2025 at a 4.5% CAGR during the forecast period, according to a new report by Grand View Research, Inc. This growth can be attributed to increased awareness about physical appearance, particularly among women.

Breast reconstruction is considered to be one of the top 5 cosmetic surgical procedures in U.S. since 2006. According to estimates, there has been a 39.0% increase in this procedure since 2000 and a 3.0% rise since 2015. Thus, with rising number of reconstruction procedures being performed, demand for associated products such as implants and tissue expanders has also increased.

According to the Agency for Healthcare Research and Quality, the number of women undergoing mastectomy procedures has increased by 36.0% during the period of 2005to 2013. Increasing prevalence of breast cancer, high mortality rate associated with it, and growing number of mastectomies being performed as a result are some of the factors anticipated to drive demand for implants and tissue expanders.

Furthermore, availability of advanced technologies in this field has supported market growth. For instance, single-stage breast reconstruction has evolved as an innovative technique that combines tissue expanders and implants into a single product.

Browse Details of Report @
https://www.grandviewresearch.com/industry-analysis/north-america-breast-reconstruction-market

Further key findings from the study suggest:

By product, tissue expanders held the largest market share in 2017 and the segment is anticipated to exhibit significant growth over the forecast period due to their high application in mastectomy and lumpectomy surgeries
Breast implants generated significant revenue in 2017 owing to significant concern among people to improve or alter their physical appearances
Round shaped implants dominated the market in 2017. These result in soft, round, and accurately proportioned breasts and eliminate any risk arising from implant rotation
Round shaped expanders are also expected to witness lucrative growth over the forecast period due to their ability to minimize visibility of implant ripples through the skin
Anatomical shaped products are expected to show significant CAGR over the forecast period as they present lower risk of capsular contracture as compared to smooth implants and also give a natural-looking appearance
U.S. dominated the regional market in 2017 due to increase in number of breast reconstruction surgeries in the country
Canada is anticipated to show significant growth over the forecast period due to rising prevalence of breast cancer among the Canadian population
Some of the major manufacturers are Mentor Worldwide LLC; Sientra, Inc.; IDEAL IMPLANT INCORPORATED; and Allergan.

About Us:
Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, the company offers market intelligence studies ensuring relevant and fact-based research across a range of industries including technology, chemicals, materials, healthcare and energy.

Contact:
Sherry James
Corporate Sales Specialist, USA
Grand View Research, Inc
Phone: 1-415- 349-0058
Toll Free: 1-888- 202-9519
Email: sales@grandviewresearch.com
For More Information: https://www.grandviewresearch.com

Amniotic Membrane Market Report | 12.6% CAGR Growth till 2025

The global Amniotic Membrane Market size is expected to reach USD 5.81 billion by 2025, according to a new report by Grand View Research, Inc. The market is estimated to witness a CAGR of 12.6% during the forecast period. Rise in trauma, burn cases and resulting surgeries along with increasing awareness regarding the benefits of these products are boosting the market growth. Rising number of cosmetic surgeries performed is also anticipated to drive the market during the forecast period. Amniotic membrane is also used in the treatment of a large number of ocular surface diseases as it protects surfaces from microbial colonization preventing the risk of infections.

Moreover, presence of growth factors including basic Fibroblast Growth Factor (bFGF), Transforming Growth Factors (TGFs), Epidermal Growth Factor (EGF), Vascular Endothelial Growth Factor (VEGF), Nerve Growth Factor (NGF), and Keratinocyte Growth Factor (KGF) in amniotic membranes promote wound healing, accelerating its adoption globally. Thus, its benefits, such as anti-inflammatory properties, reduced fibrosis and scarring at the site of surgery, pain reduction, and wound healing properties, are also fueling the demand. These products are thus most commonly used in surgeries, treatment of venous, pressure, and diabetic foot ulcers, ophthalmology, and in the management of chronic wounds.

The American Association of Tissue Banks is a non-profit organization that regulates tissue donation in U.S. Presence of such tissue banks ensures zero disease transmission, which, in turn, propels market growth. Furthermore, a number of institutes are trying to introduce novel areas of applications for these products by focusing on the research activities in stem cell and regenerative medicines. This factor is also likely to support market expansion. The use of cryopreserved amniotic membrane is largely seen in hospitals, Ambulatory Surgical Centers (ASCs), and specialty clinics. Lyophylization of the tissue post donation preserves the histological and biological activity of the tissue facilitating faster wound recovery.

Request a sample copy or view summary of this report@ https://www.grandviewresearch.com/industry-analysis/amniotic-membrane-market

Further key findings from the study suggest:

Cryopreserved is expected to be the dominant segment in future as it’s highly effective and ensures preservation of histological and biological properties
Surgical wounds segment is projected to witness high growth due to increasing usage of these products for surgical applications
Specialty clinics are anticipated to register the highest CAGR during the forecast period due to increasing number of cosmetic and reconstructive surgeries being performed
North America is a leading regional market owing to presence of a large number of key companies and high incidence of chronic and infectious diseases
The Asia Pacific region is expected to record the highest CAGR during the forecast period due to growing population and rising incidence of chronic diseases and burn injuries
Major companies in the amniotic membrane market include Alliqua BioMedical Inc.; Amnio Technology, Applied Biologics LLC; Human Regenerative Technologies DermaSciences; Katena Products, MiMedx Group Inc.; and Skye Biologics, Inc.

About Us:
Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, the company offers market intelligence studies ensuring relevant and fact-based research across a range of industries including technology, chemicals, materials, healthcare and energy.

Contact:
Sherry James
Corporate Sales Specialist, USA
Grand View Research, Inc
Phone: 1-415- 349-0058
Toll Free: 1-888- 202-9519
Email: sales@grandviewresearch.com
For More Information: https://www.grandviewresearch.com

Capillary Blood Collection Devices Market Analysis Report by Product and Application, 2025

The global Capillary Blood Collection Devices Market size is expected to reach USD 1.75 billion by 2025, according to a new report by Grand View Research, Inc., progressing at a CAGR of 5.4% during the forecast period. Increasing incidence of chronic, infectious, and autoimmune diseases are some of the major factors propelling market growth owing to the rising number of blood tests globally. Capillary blood draw technique has been most widely used for glucose and hemoglobin testing in clinics and hospitals. Ease of usage and minimally invasive nature also makes it ideal for home care diagnosis and testing, thereby boosting the market’s growth potential. The use of this technique in conjugation with PoC diagnostics has become the chosen mode of testing in remote and ambulatory health settings.

Blood gas detection, leukocyte & metabolite count, biomarker, nucleic acid, blood glucose, ferritin, lactate, effect of vitamin K-antagonist, and heavy metal ions analysis is commonly done using these samples. Thus, with the rising adoption of rapid PoC diagnostics, the usage of these devices is anticipated to increase in the near future.

Chronic diseases are a global healthcare problem with over half of the adult population in the U.S. suffering from chronic diseases, which contribute to over 75% of the total healthcare cost in the nation. Thus, the rising number of infectious and chronic diseases creates a huge demand for diagnostic testing, thereby propelling the growth of these collection devices.

Capillary blood draw technique is most often used in the case of pediatric patients as it is difficult to draw venous and arterial blood from infants. Capillary blood draw is preferred in many ICU settings as patients lose a large amount of blood during surgeries. Other blood drawing techniques are more invasive and might result in delays in the healing process or pose a risk of contamination. Ease of usage and effectiveness is another factor facilitating the use of these devices for home care diagnosis and testing, typically in case of diabetics.

Request a sample copy or view summary of this report@
https://www.grandviewresearch.com/industry-analysis/capillary-blood-collection-devices-market

Further Key Findings From the Report Suggest:

Plastic devices held the largest market share in 2017 owing to their lightweight, cost-effective, and biocompatible nature coupled with extensive usage in medical devices
Durability, non-porous nature, and impermeability are boosting the demand for glass devices
Plastic and glass-based collection devices are anticipated to dominate the market throughout the forecast horizon during the forecast period due to their extensive use in the manufacture of medical devices and other related products.
North America will lead the market throughout the forecast period owing to the existence of a large number of major market players and high incidence of chronic and infectious diseases
The Asia Pacific market is expected to rise at the highest CAGR during the same period. High population along with the rising incidence of chronic diseases such as cancer and diabetes are the major factors contributing to the growth of the regional market

Some of the major players are Becton, Dickinson and Company; NIPRO Europe Corporation; Sarstedt AG & Co; Thermo Fisher Scientific Inc.; Terumo Medical Corporation; B Braun Melsungen AG; Kabe Labortechnik GmbH; Greiner Bio One International GmbH; Cardinal Health; and Owen Mumford Ltd.

About Us:
Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, the company offers market intelligence studies ensuring relevant and fact-based research across a range of industries including technology, chemicals, materials, healthcare and energy.

Contact:
Sherry James
Corporate Sales Specialist, USA
Grand View Research, Inc
Phone: 1-415- 349-0058
Toll Free: 1-888- 202-9519
Email: sales@grandviewresearch.com
For More Information: https://www.grandviewresearch.com

Monday, 9 November 2020

Dental Chair Market by Key Players - Austin Dental Equipment Company (A-Dec, Inc.); Midmark; Craftsmaster Contour Equipment, Inc.

The global Dental Chair Market is expected to reach USD 639.4 million by 2026, according to a new report by Grand View Research, Inc., exhibiting a CAGR of 4%. Dental chairs are vital for any dental procedure. Rising need for comfortable chairs during surgeries and increasing demand for dental aesthetics are expected to boost growth during the forecast period. Therefore, key players are increasingly focusing on patient comfort while designing these chairs. Technological advancements such as addition of imaging systems, operating lights, footswitches, extended trays, and x-ray viewers have led to the introduction of innovative designs, thereby creating growth opportunities for market players.

Advancements in infrastructure in the healthcare and medical industry are expected to propel dental chair market growth. Moreover, increasing prevalence of oral diseases & dental disorders worldwide due to unhealthy eating habits, high sugar in daily diet, smoking, family history, and infections, such as AIDS or HIV, is boosting the demand for various dental equipment. This, in turn, is fueling the demand for dental examinations, thereby driving overall growth.

North America held the largest share in 2018 owing to factors such as high prevalence of dental disorders, growth in geriatric population, and improvement in infrastructure. Besides periodontal diseases, other common dental diseases prevalent in North America are tooth decay, bad breath, tooth erosion, and sensitivity, among others.

Request a free sample copy or view report summary: Dental Chair Market Report

Dental Chair Market Report Highlights

The powered chairs segment held the largest share in 2018 and is expected to grow at a considerable rate during the forecast period
Increasing number of innovations and growing preference by dental surgeons can be attributed to the high share of this segment
Ceiling mounted design held a significant share of the market in 2018 as this design offers better assistance to dentists in performing multiple surgeries
Among all applications, examination held the largest share owing to increasing awareness about oral benefits and rising incidence of several dental diseases
Asia Pacific is expected to grow at a significant rate during the forecast period due to rising number of campaigns & initiatives by several organizations to create awareness about optimal dental health & hygiene and growing number of upgrades.

Electronic Lab Notebook Market Trends, Segmentation and Future Scope

The global Electronic Lab Notebook Market size is expected to reach USD 768.2 million by 2026, according to a new report by Grand View Research, Inc. It is projected to expand at a CAGR of 4.8% during the forecast period. Increasing requirement for life science and pharma industries to comply with regulatory requirements has promoted the incorporation of Electronic Lab Notebook (ELN) as it helps simplify the lab process and reduce time.

Rising demand for automated laboratory process such as cloud based electronic lab notebook, ELN embedded with SDMS solutions and supportive government initiatives, are expected to propel the market over the forecast period. Asia Pacific is expected to exhibit lucrative growth over the forecast period owing to increasing demand of Contact Research Organizations (CROs). Moreover, reduced operational cost, remote access, real time data tracking are contributing to the rising demand.

Browse Details of Report @
https://www.grandviewresearch.com/industry-analysis/electronic-lab-notebook-eln-market

Further key findings from the report suggest:

Increasing demand for automation in lab activities are anticipated to create growth opportunities in near future
Cross disciplinary accounted for the largest revenue share of the product segment in 2018, owing to its usage in multiple disciplines and other added advantages such as customized features and coordination across the domain
Web hosted/cloud based delivery mode held the largest share of electronic lab notebook market in 2018 owing to its real time data analysis, remote access, and reduced IT manpower
Proprietary held the largest revenue share of the license segment due to the increasing adoption in life science and pharmaceutical industries as compared to open source ELN
North America held the dominant market share in 2018, due to supportive government initiatives and presence of large number of industry players
Asia Pacific is anticipated to witness lucrative growth due to increase in number of CROs and untapped opportunities
Some of the key companies are Thermo Fisher Scientific, Inc.; Core Informatics;Arxspan, LLC; LabVantage Solutions, Inc.; Benchling, Inc.; LabLynx, Inc.; Agilent Technologies; Dassault Systemes SE; KineMatik Inc.; and Abbott Informatics

Lancets Market by B. Braun Melsungen, Medline Industries, Roche Diagnostics

The global Lancets Market size is expected to reach USD 5.1 Billion by 2027, registering a CAGR of 5.6% over the forecast period, according to a new report by Grand View Research, Inc. The market is primarily driven by increasing incidence of infectious diseases, coupled with advancement in the field of diagnostic testing. Furthermore, increasing awareness about self-monitoring of blood glucose, coupled with improved accuracy in self diagnostic among patients, is adding to the market growth.

Rapidly changing lifestyle such as unhealthy food, consumption of alcohol, and lack of physical activities is increasing the incidence of lifestyle associated chronic diseases. Rising government expenditure and technological advancement in the field of diabetes management are expected to drive the market. Furthermore, increasing preference for home care settings and growing trend of using advanced lancet devices, including automatic versions, are some of the factors expected to drive the market during forecast period.

Availability of lancets in different sizes and specifications is expected to increase the usage of these devices by geriatric patients. Growth of the geriatric population across the globe is also opening new avenues for the market. Aged people are more prone to infectious diseases, thereby significantly contributing to the market growth. According to the WHO, the proportion of people over 60 years is expected to reach 22% by 2050 from 12% in 2015.

Request a sample copy or view summary of this report@
https://www.grandviewresearch.com/industry-analysis/lancets-market

Further key findings from the study suggest:

North America accounted for the largest share in 2019 owing to high adoption rate, frequent new product launch, presence of key market players, and advanced healthcare service industry
Asia Pacific is expected to witness robust growth during the forecast period owing to rising awareness about self-monitoring of blood glucose
By product, the safety lancets segment dominated the market in 2019 owing to the low cost and advanced features of the products
By application, blood glucose testing accounted for the largest share in 2019 due to presence of a large diabetes population
By end use, the homecare settings segment is expected to witness the fastest growth over the forecast period due to low cost and increasing need for diagnostic testing
The lancets market is highly fragmented due to presence of a number of players
The leading players in the industry include B. Braun Melsungen, Medline Industries, Roche Diagnostics, Becton, Dickinson and Company, Ypsomed, HTL-Strefa S.A, Terumo Corporation, Owen Mumford, Arkray, AgaMatrix, Abbott, Nipro Medical Corporation, and Ypsomed.

About Us:
Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, the company offers market intelligence studies ensuring relevant and fact-based research across a range of industries including technology, chemicals, materials, healthcare and energy.

Contact:
Sherry James
Corporate Sales Specialist, USA
Grand View Research, Inc
Phone: 1-415- 349-0058
Toll Free: 1-888- 202-9519
Email: sales@grandviewresearch.com
For More Information: https://www.grandviewresearch.com

Thursday, 5 November 2020

Heart Failure POC & LOC Devices Market Analysis Report by Technology and End Use

The global Heart Failure POC & LOC Devices Market size is expected to reach USD 129.69 million by 2025 and is projected to grow at a CAGR of 16.2%, according to a new report by Grand View Research, Inc. A paradigm shift in diagnostic sectors from late-stage disease detection to early identification of diseases as a viable strategy to curb rising healthcare costs has driven the market. This shift has led to the development of disposable and low-cost LOC devices that integrate various sensors and associated accessories in a single space for detection of the cardiac biomarkers from a single specimen to evaluate the risk of having a heart attack.

Furthermore, the development of predictive modeling techniques-based decision support software to analyze the data measured by the LOC assays to enable therapy monitoring is one of the key market drivers. Also, ongoing studies on the application of saliva-based nano-biochip tests for measuring myocardial infarction is driving organic revenue growth.

POC testing exhibits potential savings across various settings, including hospitals, general practice, and remote areas. In the U.S., the employment of POC devices resulted in a 20% decrease in hospital admissions to the chest pain unit, resulting in substantial savings in time and costs.

In the cardiac observation unit (U.S.), the implementation of POC troponin testing helped reduce hospital stays, decrease admission rates, and remove the need for multiple costly procedures, resulting in 25% cost saving per patient. Furthermore, the integration of smartphones and apps in POC diagnostics for managing the cardiac health of an individual is one of the significant innovations in Heart Failure POC & LOC Devices market.

Request a sample copy or view summary of this report@
https://www.grandviewresearch.com/industry-analysis/heart-failure-poc-loc-devices-market

Further key findings from the report suggest:

Proteomic analysis includes products that test protein markers, such as troponin, myoglobin, and Creatine Kinase MB Isoenzyme (CK-MB)
This segment accounted for the leading revenue share, as most of the currently available products are based on testing of protein markers
Increasing implementation of microfluidic LOC technology for assessing putative biomarkers has led to the largest revenue share of this technology
Microfluidic technologyhas been implemented for various biological applications, such as immunohybridization techniques, enzymatic assays, PCR, and others
Clinics that include physician’s office, pharmacy & retail clinics, urgent care clinics, and non-practice clinics are the key revenue generating end-users
A high usage rate of POC devices by general practitioners for rapid investigation, deciding early treatment, timely referral, and less uncertainty for patients has driven the revenue growth through clinics
The U.S. dominated the global Heart Failure POC & LOC devices market owing to the presence of a substantial number of primary care clinics that are deploying POC cardiac marker test as a measure for early detection of heart failure
Expanding urbanization and increasing geriatric population underpin the demand for robust and improved healthcare services such as POC diagnostics for routine cardiac health monitoring in Asian countries
Moreover, initiatives are undertaken for training young healthcare personnel about POC cardiac troponin T/cardiac troponin I biomarkers
This, in turn, is anticipated to result in the surging adoption rate of POC devices in Asian countries
Abbott, Siemens Healthineers, Danahar, and F. Hoffmann-La Roche Ltd are some key participants operating in the space
Companies are engaged in mergers and acquisitions of emerging players. Acquisition of Alere by Abbott, Beckman Coulter, Inc by Danahar, and Accriva Diagnostics by Instrumentation Laboratory are some examples of acquisitions in this market